Profile | GDS4284 / 229497_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 136.713 | 43 |
GSM687648 | Patient 402 control | 779.134 | 70 |
GSM687653 | Patient 403 control | 577.801 | 67 |
GSM687658 | Patient 404 control | 885.535 | 72 |
GSM687663 | Patient 411 control | 943.087 | 73 |
GSM687668 | Patient 422 control | 454.769 | 62 |
GSM687673 | Patient 424 control | 307.082 | 55 |
GSM687678 | Patient 425 control | 646.706 | 67 |
GSM687683 | Patient 427 control | 220.011 | 48 |
GSM687688 | Patient 428 control | 1212.4 | 77 |
GSM687695 | Patient 441 control | 661.252 | 67 |
GSM687699 | Patient 443 control | 393.421 | 58 |
GSM687704 | Patient 444 control | 135.729 | 40 |
GSM687707 | Patient 448 control | 269.302 | 51 |
GSM687712 | Patient 449 control | 470.305 | 62 |
GSM687719 | Patient 450 control | 346.82 | 56 |
GSM687724 | Patient 451 control | 514.812 | 64 |
GSM687728 | Patient 452 control | 582.527 | 66 |
GSM687646 | Patient 401 treated 24h | 249.779 | 52 |
GSM687649 | Patient 402 treated 24h | 958.054 | 73 |
GSM687665 | Patient 411 treated 24h | 1093.3 | 75 |
GSM687651 | Patient 402 treated 4 weeks | 525.284 | 64 |
GSM687667 | Patient 411 treated 4 weeks | 1024.98 | 74 |
GSM687670 | Patient 422 treated 24h | 654.747 | 67 |
GSM687671 | Patient 422 treated 4 weeks | 583.055 | 66 |
GSM687654 | Patient 403 treated 24h | 446.567 | 63 |
GSM687675 | Patient 424 treated 24h | 308.334 | 55 |
GSM687685 | Patient 427 treated 24h | 99.5857 | 34 |
GSM687656 | Patient 403 treated 4 weeks | 562.63 | 66 |
GSM687677 | Patient 424 treated 4 weeks | 197.927 | 48 |
GSM687687 | Patient 427 treated 4 weeks | 121.274 | 40 |
GSM687692 | Patient 428 treated 4h | 1528.03 | 80 |
GSM687716 | Patient 449 treated 4h | 595.939 | 67 |
GSM687722 | Patient 450 treated 4h | 267.394 | 51 |
GSM687680 | Patient 425 treated 24h | 668.602 | 68 |
GSM687690 | Patient 428 treated 24h | 1550.34 | 81 |
GSM687700 | Patient 443 treated 24h | 756.516 | 68 |
GSM687705 | Patient 444 treated 24h | 92.6426 | 34 |
GSM687714 | Patient 449 treated 24h | 407.79 | 61 |
GSM687721 | Patient 450 treated 24h | 140.974 | 37 |
GSM687682 | Patient 425 treated 4 weeks | 547.092 | 66 |
GSM687694 | Patient 428 treated 4 weeks | 1437.76 | 79 |
GSM687702 | Patient 443 treated 4 weeks | 641.156 | 66 |
GSM687718 | Patient 449 treated 4 weeks | 415.622 | 61 |
GSM687723 | Patient 450 treated 4 weeks | 159.967 | 42 |
GSM687661 | Patient 404 treated 4h | 845.572 | 71 |
GSM687710 | Patient 448 treated 4h | 31.6775 | 17 |
GSM687726 | Patient 451 treated 4h | 684.437 | 68 |
GSM687730 | Patient 452 treated 4h | 866.833 | 71 |
GSM687660 | Patient 404 treated 24h | 831.723 | 73 |
GSM687697 | Patient 441 treated 24h | 547.875 | 64 |
GSM687709 | Patient 448 treated 24h | 251.578 | 51 |
GSM687725 | Patient 451 treated 24h | 633.18 | 67 |
GSM687729 | Patient 452 treated 24h | 762.692 | 71 |
GSM687727 | Patient 451 treated 4 weeks | 673.523 | 68 |
GSM687731 | Patient 452 treated 4 weeks | 590.042 | 66 |